๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacogenetics of smoking cessation therapy

โœ Scribed by Gustavo L. Kortmann; Cristina J. Dobler; Lisiane Bizarro; Claiton H.D. Bau

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
152 KB
Volume
9999B
Category
Article
ISSN
1552-4841

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

High-impact therapy for smoking cessatio
High-impact therapy for smoking cessation
โœ Ellen A. Dornelas; Jeffrey J. Magnavita ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB

## Abstract Cigarette smoking is the leading cause of preventable death and disabilityโ€”and thus an issue of considerable importance to psychotherapists. The majority of smokingโ€cessation programs available to the public uses an effective group format, but it remains underused. Many smokers who seek

Combined counseling and bupropion therap
Combined counseling and bupropion therapy for smoking cessation: identification of outcome predictors
โœ Maria Caterina Grassi; Domenico Enea; Rosanna Marchetti; Alessio Maria Caricati; ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 149 KB

## Abstract Because some smokingโ€induced pathologies improve upon discontinuation, strategies have been developed to help smokers quit. The aim of this study was to measure the rate of smokers still abstinent one year after one cycle of a sixโ€week group counseling given alone or in combination with